Epilepsy Surgery Flashcards
Treatment options for medically refractory epilepsy
- Surgical resection
- VNS
- Multiple subpial transections
- DBS
- OThers: DBS, transgeminal nerve stimulation, external VNS, transcranial direct current stimulation, ketogenic diet
Best predictor of postoperative adequacy
Preoperative cognitive and psychosocial status
-Lower the preoperative cognitive and psychosocial status, the lower the risk of further decline
Intracarotid Amobarbital Procedure (Wada)
Helps lateralize language dominance and memory function
Can lateralize seizure onset (side with poor memory likely seizure onset)
Surgical Outcomes
At 1 year, patient seizure free 58% compared to 8% on medication
People with surgery
Had less CPS and better quality of life
10% had adverse side effects - language and memory related problems
Early Randomized Surgical Epilepsy Trial (ERSET)
Outcomes:
Seizure freedom 11/15 pts in surgical 0/23 in medical group
QOL better in surgical group
Memory decline in 36% of pts after surgery
Adverse events: stroke - surgical case. 3 with status in medical group
Resective surgery +ASM in patients with new refractory MTLE results in lower probability of seizures in second year
Surgical Methods
Temporal lobe surgery Lobectomy Resection of epileptogenic zone Lesionectomy Corpus Callosotomy Hemispherectomy Multiple subpial transection
Different Methods for temporal lobectomy
Standard (en bloc) anterior temporal lobectomy (ATL) - 3-6 cm of anterior temporal neocortex + 1-3 cm of MTS (amygdala + hippocampus)
Modified + limited neocortical resection = 3.5cm from temporal pole sparing superior temporal gyrus (avoid language deficits)
Selective amygdalohippocampectomy
Stereotactic radiosurgery
Standard Amygdalohippocampectomy
Attempts to preserve lateral temporal cortex out of concern for language deficits
- Resect up to 4-4.5 cm on dominant
- Resect u up to 6-6.5cm on nondominant
- Preserves the neocortical areas
Outcomes following Temporal lobe surgery
seizure free rates:
At 12 months - 82%
At 24 months 76%
At 63 months - 64%
Complete or better seizure outcome was associated with significantly better QOL
Risk factor for seizure recurrence was reduction in ASM
Standard Anterior Temporal Lobectomy OUtcomes
Seizure freedom 89%
Engel Class I or II - 94%
*Highest concordance was with video EEG > PET> MRI > Wada > SPECT/Neuropsych
Inferior Temporal approach to Standard Anterior Temporal Lobectomy
safe and effective with low morbidity and mortality.
Complications: delayed SDH, wound infections, delayed ICH, small lacunar stroke, one transient frontalis nerve palsy
Selective Amygdalohippocampectomy (SAH)
Aim: Minimize neurocognitive side effects of temporal lobectomy
Result: Some improved, some no clear benefit or event significant verbal memory deficits (in dominant SAH)
Risk of Neurocognitive Deficits and Risk factors following ATL
Larger temporal lobe resection associated with better seizure control, but also high risk of cognitive outcome
> 2 cm for mesial
4cm for neocortical
Standard vs Selective Temporal Lobe Surgery
ATL is more likely to achieve Engel Class I outcome compared to SAH
Thus, standard ATL confers better chance of seizure freedom
Comparison of right vs left temporal lobectomy
Post-operative after Left temporal lobectomy:
- Verbal memory decline
- Performance intellegence decline
Post-operative after RTL:
-visuospatial memory outcome
More resection is associated with worse functioning
Outcome following nonlesional partial epilepsy surgery
Engel Class I 81% at 6mo 78% at 1 year 76% at 2 years 74% at 5 years 72% at 10 years
Positive Predictors for outcome for nonlesional epilepsy surgery
Seizure control at 1 year –> 92% prob of remission at 10 years
Negative Predictors for nonlesional epilepsy surgery
Extratemporal seizure focus
Previous surgery
Male gender
Normal tissue pathology
Outcome following ATL in Nonlesional TLE
Complete seizure freedom rates:
1 year 76%
2 years 66%
7 years 47%
*Memory decline reported with dominant hippocampus resection
Negative predictors (risk factors) for outcome of nonlesional TLE surgery
Higher baseline seizure frequency
Preoperative GTCs